Publications 2025

Cochrane reviews - published

  1. Cagnotto G, Bruschettini M, Stróżyk A, Scire CAlberto, Compagno M. Tumor necrosis factor (TNF) inhibitors for the treatment of psoriatic arthritis. Cochrane Database of Systematic Reviews 2025, Issue 2. Art. No.: CD013614
  2. Cagnotto G, Juhl CB, Ahlström F, Wikström F, Bruschettini M, Petersson I, Dreyer L, Compagno M. Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis. Cochrane Database of Systematic Reviews 2025, Issue 2. Art. No.: CD013715
  3. Urlesberger B, Cabano R, Soll G, Oei JL, Pahl A, Schmölzer GM, Bruschettini M. Acupuncture for neonatal abstinence syndrome in newborn infants. Cochrane Database of Systematic Reviews 2025, Issue 2. Art. No.: CD014160
  4. King E, Horn D, Gluchowski N, Bruschettini M, Fiander M, Soll R, O'Reilly D. Safety and efficacy of proton pump inhibitors in preterm infants with gastroesophageal reflux disease. Accepted for publication, November 2024
  5. Färnqvist K, Bruschettini M, Olsson E, Garratt A, Paraskevas T, Soll R, Persad E. Clinical rating scales for assessing pain in newborn infants. Accepted for publication, January 2025

 

Cochrane reviews - submitted

  1. Cabano R, Abdallat  H, Abuhammour R, Soll G, Oei JL, Schmölzer GM, Bruschettini M. Acupuncture for procedural pain in newborn infants. Submitted April 2024
  2. Darlison P, Moresco L, Bruschettini M, Nussbaumer-Streit B, Gisselsson-Solen M. Decongestants and antihistamines for acute otitis media in children. Submitted October 2024
  3. Bruschettini M, Moberg T, O'Donnell CP, Davis PG, Morley CJ, Moja L, Calevo MG. Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes. Submitted October 2024
  4. Bodrero E, Isaza Lopez MC, Greisen G, Gluud C, Bruschettini M. Cerebral near-infrared spectroscopy monitoring for prevention of brain injury in very preterm infants. Submitted February 2025

 

Cochrane reviews in preparation:

  1. Kinoshita M, Del Giovane C, Borys F, Mitra S, Hall R, Wróblewska-Seniuk K, Soll R, Bruschettini M. Methylxanthine for preventing morbidity and mortality in preterm infants: a network meta-analysis. Cochrane Database of Systematic Reviews 2023, Issue 12. Art. No.: CD015058
  2. Olsson E, Sibrecht G, Conde-Agudelo A, Díaz-Rossello JL, Ehret D, Bruschettini M. Kangaroo mother care to reduce morbidity and mortality in low birthweight infants
  3. Romantsik O, Sharifan A, Fiander M, Ng E, Bruschettini M. Midazolam for sedation of infants in the neonatal intensive care unit
  4. Borys F, Sibrecht G, Wróblewska-Seniuk K, Magagnoli C, Fiander M, Ringsten M, Bruschettini M. Indications for caffeine initiation in preterm infants.
  5. Urru S, Geist M, Carlinger R, Bodrero E, Giordano P, Bruschettini M. Strategies for cessation of caffeine administration in preterm infants. Update 2025
  6. O'Reilly D, Fiander M, Bruschettini M, Soll R. Prophylactic vitamin K for vitamin K deficiency bleeding in neonates. Update 2025
  7. Wróblewska-Seniuk K, Lenells M, Prescott Glenton M, Fiander M, Soll R, Bruschettini M. Multisensorial stimulation for promoting development and preventing morbidity in preterm infants.
  8. Lenells M, Prescott Glenton M, Wróblewska-Seniuk K, Fiander M, Soll R, Bruschettini M. Olfactory stimulation for promoting development and preventing morbidity in preterm infants.
  9. Prescott Glenton M, Wróblewska-Seniuk K, Lenells M, Fiander M, Soll R, Bruschettini M. Vestibular stimulation for promoting development and preventing morbidity in preterm infants.
  10. Nissimov S, Sibrecht G, Weerasekara I, Bartocci M, Bruschettini M. Minimizing blood sampling in preterm infants.
  11. Bodrero E, Isaza C, Fiander M, Soll R, Bruschettini M. Methylxanthines for the prevention or treatment of intermittent hypoxemia or respiratory insufficiency in late preterm infants.
  12. Prescott Glenton M, Geist M, Olsson E, Fiander M, Soll R, Bruschettini M. Infant positioning for promoting development and preventing morbidity in preterm infants.
  13. Wróblewska-Seniuk K, Wallman-Stokes A, Edwards E, Fiander M, Bruschettini M, Soll R. Financial incentives for family members of hospitalized neonates for improving family engagement.
  14. Borys F, Prescott Glenton M, Fiander M, Soll R, Bruschettini M. Clustering of nursery care activities for promoting development and preventing morbidity in preterm infants.
  15. Moresco L, Bruschettini M, Macchi M, Calevo MG. Salbutamol for transient tachypnea of the newborn (third update)

 

Cochrane protocols - published

  1. Olsson E, Prescott Glenton M, Titlestad KBerg, Fiander M, Soll R, Bruschettini M. Individualized developmental care interventions for promoting development and preventing morbidity in preterm infants. Cochrane Database of Systematic Reviews 2025, Issue 1. Art. No.: CD016026
  2. Badura A, Faas D, Gabriel A, Wellmann S, Cracknell J, Fiander M, Soll R, Bruschettini M. In-hospital motor interventions to prevent neurodevelopmental impairment in preterm infants: a scoping review. Accepted for publication, February 2025
  3. Pessara S, Boldor M, Faravelli F, Fiander M, Jørgensen KJ, Soll RF, Bruschettini M. Next-Generation Sequencing (NGS) techniques for pre-symptomatic identification of genetic diseases in newborns. Accepted for publication, February 2025

 

Cochrane protocols - submitted

  1. Weerasekara I, Styrmisdóttir L, Ringsten M, Orsini N, Andersson O, Mukiira C, Sharma S, Fiander M, Andersson A, Vaag A, Nilsson PM, Bruschettini M. The effect of birth weight and prematurity on the incidence of type 2 diabetes mellitus: a dose-response meta-analysis of observational studies. Submitted June 2024
  2. Olsson E, Romantsik O, Lundgren P, Fiander M, Snellman A, Hellstrom A, Bruschettini M. Pain management for screening or treatment of retinopathy of prematurity. Submitted September 2024
  3. Badura A, Hiekel J, Saladino A, Murature D, Wellmann S, Fiander M, Bruschettini M. Motor interventions initiated prior hospital discharge to prevent neurodevelopmental impairment in preterm infants. Submitted September 2024
  4. Bäcke P, Thernström Blomqvist Y, Björk M, Fiander M, Soll R, Bruschettini M. Training to increase parental participation in care decisions and delivery for infants in neonatal units. Submitted October 2024
  5. Borys F, Bruschettini M, Sibrecht G, Mohammad Khuzaini A, Fiander M, Soll R. Higher initial doses of surfactant for the prevention or treatment of respiratory distress syndrome in preterm infants. Submitted October 2024
  6. Cagnotto C, Bäcklund R, Bengtsson A, Bruschettini M. Immunosuppressants and immunomodulators for IgG4-related disease. Submitted November 2024
  7. Garegnani L, Escobar Liquitay CM, Esteban I, Russo C, Bruschettini M, Franco J. Monoclonal antibodies for preventing respiratory syncytial virus infection in children. A network meta-analysis. Submitted February 2025
  8. Sotiropoulos J, Soll R, Fiander M, Bruschettini M, Oei JL; Kapadia V, Seidler AL. Delivery room oxygen titration strategies to improve preterm infant outcomes. Submitted February 2025
  9. Bolanos L, Borys F, Pahl A, Fiander M, Cracknell J, Gautham KS, Soll RF, Bruschettini M. Intratracheal instillation of corticosteroids combined with surfactant for the prevention of chronic lung disease in preterm infants. Submitted March 2025

Cochrane protocols in preparation:

  1. Darlison P, Bruschettini M, Gisselsson-Solén M, Jenniskens K, Hooft L. Artificial intelligence for diagnosing acute otitis media.
  2. Wróblewska-Seniuk K, Arham M, Geist M, Björklund M, Rose CJ, Sibrecht G, Borys F, Bruschettini M. Neonatal morbidity in late preterm and early term infants
  3. Lööf E, Skogman Hedin B, Cabano R, Sylvan R, Bruschettini M. Acupuncture for the treatment of infantile colic.
     

 

Peer-reviewed articles in other Journals

  1. Ringsten M, Färnqvist K, Bruschettini M, Johansson M. Inclusion, characteristics and methodological limitations of systematic reviews in doctoral theses: A cross-sectional study of all universities in Sweden. Cochrane Evidence Synthetis and Methods;3:e70015
  2. Nilsonne G, Wieschowski S, DeVito NJ, Salholz-Hillel M, Ahnström L, Bruckner T, Klas K, Suljic T, Yerunkar S, Olsson N, Cruz C, Strzebonska K, Småbrekke L, Wasylewski MT, Bengtsson J, Ringsten M, Schuster A, Krawczyk T, Paraskevas T, Raittio E, Herczeg L, Hesselberg JO, Karlsson S, Borana R, Bruschettini M, Mulinari S, Lizárraga K, Siebert M, Hildebrand N, Ramakrishnan S, Janiaud P, Zavalis E, Franzen D, Boesen K, Hemkens LG, Naudet F, Possmark S, Willén RM, Ioannidis JP, Strech D, Axfors C. Results reporting for clinical trials led by medical universities and university hospitals in the Nordic countries was often missing or delayed. Journal of Clinical Epidemiology, Feb 1:111710. doi: 10.1016/j.jclinepi.2025.111710.
  3. Rose C, Geist M, Bruschettini M. Count data, rates, rate differences, and rate ratios in meta-analysis: A tutorial. Cochrane Evidence Synthesis and Methods 2025; 3:e70022.
  4. Toews M, Minozzi S, Stegeman BH, Cinquini M, Meerpohl JJ, Färnqvist K, Bruschettini M, Toews I. Rating down for publication bias is rare in Cochrane reviews: a cross sectional study. Journal of Clinical Epidemiology, submitted May 2024
  5. Rose C, Ringsten M. ChatGPT & Risk of bias. In preparation
  6. Shcherbatiuk K, Magagnoli C, Susca F, Caratozzolo D, Fiander M, Bruschettini M, Romantsik O. Devices to improve success of peripheral vascular catheterization in newborn infants. In preparation
  7. Borys F, Alarcón Garavito G, Osman AA, Fiander M, Russo C, Bruschettini M, Sibrecht G. Strategies for caffeine administration in preterm infants. In preparation
  8. Rogova O, Herzog K, Carolo dos Santos K, Frilund JP, Al-Majdoub M, Bruschettini M, Ley D, Spégel P. Absence of caffeine impact on hepatic metabolism in healthy conditions: Insights from human cross-sectional studies, in vivo and in vitro experiments. In preparation